Caplin Point Laboratories’ arm receives EIR for Injectable facility

25 Jul 2019 Evaluate

Caplin Point Laboratories’ wholly owned subsidiary -- Caplin Steriles has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the recently concluded inspection in June 2019.

USFDA has completed inspection at Caplin Steriles’ Injectable site at Gummidipoondi between June 6 and June 14, 2019. This was the third successful USFDA audit at the plant since 2016. 

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1662.65 2.40 (0.14%)
09-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.35
Dr. Reddys Lab 1212.35
Cipla 1224.25
Zydus Lifesciences 902.15
Lupin 2296.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×